Xu Guiwen, Xiao Wei, Sun Pengqi, Sun Yuanjun, Yang Xinyu, Yin Xiaomeng, Liu Yang
Institute of Cardiovascular Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
J Lipid Res. 2025 Jan;66(1):100713. doi: 10.1016/j.jlr.2024.100713. Epub 2024 Nov 22.
Diastolic dysfunction in aging mice is linked to mitochondrial abnormalities, including mitochondrial morphology disorders and decreases in membrane potential. Studies also show that aberrant mitochondrial lipid metabolism impairs mitochondrial function in aging cardiomyocytes. Our lipidomic analysis revealed that phosphatidylethanolamine (PE) levels were significantly decreased in aging myocardial mitochondria. Here, we investigated whether a reduction in PE levels in myocardial mitochondria contributes to mitochondrial injury as well as HFpEF pathogenesis and whether modulation of PE levels could ameliorate aging-induced HFpEF. Echocardiography was used to assess cardiac diastolic function in adult and aging mice treated with lysophosphatidylethanolamine (LPE) or saline. Mitochondrial morphologies from tissue samples were evaluated by transmission electron microscopy (TEM), while mitochondrial membrane potential and reactive oxygen species (ROS) levels were assessed using JC-1, MitoSOX, and DCFH-DA detection assays. We performed GO enrichment analysis between adult and aging mice and discovered significant enrichment in transcriptional programs associated with mitochondria and lipid metabolism. Also, mitochondrial PE levels were significantly decreased in aging cardiomyocytes. Treatment with LPE (200 μg/kg) significantly enhanced PE content in aging mice and improved the structure of mitochondria in cardiac cells. Also, LPE treatment protects against aging-induced deterioration of mitochondrial injury, as evidenced by increased mitochondrial membrane potential and decreased mitochondrial ROS. Furthermore, treatment with LPE alleviated severe diastolic dysfunction in aging mice. Taken together, our results suggest that LPE treatment enhances PE levels in mitochondria and ameliorates aging-induced diastolic dysfunction in mice through a mechanism involving improved mitochondrial structure and function.
衰老小鼠的舒张功能障碍与线粒体异常有关,包括线粒体形态紊乱和膜电位降低。研究还表明,异常的线粒体脂质代谢会损害衰老心肌细胞中的线粒体功能。我们的脂质组学分析显示,衰老心肌线粒体中的磷脂酰乙醇胺(PE)水平显著降低。在此,我们研究了心肌线粒体中PE水平的降低是否导致线粒体损伤以及射血分数保留的心力衰竭(HFpEF)的发病机制,以及调节PE水平是否可以改善衰老诱导的HFpEF。超声心动图用于评估用溶血磷脂酰乙醇胺(LPE)或生理盐水处理的成年和衰老小鼠的心脏舒张功能。通过透射电子显微镜(TEM)评估组织样本的线粒体形态,同时使用JC-1、MitoSOX和DCFH-DA检测法评估线粒体膜电位和活性氧(ROS)水平。我们对成年和衰老小鼠进行了基因本体(GO)富集分析,发现与线粒体和脂质代谢相关的转录程序有显著富集。此外,衰老心肌细胞中的线粒体PE水平显著降低。用LPE(200μg/kg)处理可显著提高衰老小鼠的PE含量,并改善心脏细胞中线粒体的结构。此外,LPE处理可防止衰老诱导的线粒体损伤恶化,线粒体膜电位升高和线粒体ROS降低证明了这一点。此外,LPE处理减轻了衰老小鼠严重的舒张功能障碍。综上所述,我们的结果表明,LPE处理可提高线粒体中的PE水平,并通过改善线粒体结构和功能的机制改善衰老诱导的小鼠舒张功能障碍。